Keyword Connections

cancer therapy

Journals

27

1 European journal of medicinal chemistry

2 Journal of ethnopharmacology

3 Environmental science and pollution research international

4 Molecules (Basel, Switzerland)

5 international journal of nanomedicine

6 seminars in cancer biology

7 Carbohydrate polymers

8 Medicine

9 drug metabolism reviews

10 Mikrochimica acta

11 artificial cells, nanomedicine, and biotechnology

12 world neurosurgery

13 medchemcomm

14 colloids and surfaces b, biointerfaces

15 current pharmaceutical design

16 Nanotechnology

17 Cells

18 nucleosides, nucleotides & nucleic acids

19 Future medicinal chemistry

20 zeitschrift fur naturforschung c, journal of biosciences

21 Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)

22 Frontiers in oncology

23 der hautarzt; zeitschrift fur dermatologie, venerologie, und verwandte gebiete

24 frontiers in molecular neuroscience

25 expert opinion on drug delivery

26 preventing chronic disease

27 current drug targets

Research Groups

0

No Research Group Connected

Bibliographies

133

1 Anticancer properties of Prunus mume extracts (Chinese plum, Japanese apricot).

2 Recent advances in graphene-based nanomaterials: properties, toxicity and applications in chemistry, biology and medicine.

3 When polymers meet carbon nanostructures: expanding horizons in cancer therapy.

4 Advances in nanomedical applications: diagnostic, therapeutic, immunization, and vaccine production.

5 Micelles As Delivery System for Cancer Treatment.

6 Maltodextrin modified liposomes for drug delivery through the blood-brain barrier.

7 Therapeutic Perspectives of Molecules from Extracts for Cancer Treatment.

8 Multi-functional core-shell FeO@Au nanoparticles for cancer diagnosis and therapy.

9 Harnessing DNA Double-Strand Break Repair for Cancer Treatment.

10 Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: A review.

11 Introduction of magnetic and supermagnetic nanoparticles in new approach of targeting drug delivery and cancer therapy application.

12 Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy.

13 [Current indications for plasma therapy in dermatology].

14 Applications of magnetoliposomes with encapsulated doxorubicin for integrated chemotherapy and hyperthermia of rat C6 glioma.

15 Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.

16 Magnetically guided targeted delivery of erythropoietin using magnetic nanoparticles: Proof of concept.

17 micrornas and chinese medicinal herbs: new possibilities in cancer therapy

18 natural killer cells for immunotherapy – advantages of cell lines over blood nk cells

19 Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review.

20 an amphiphilic peptide induces apoptosis through the mir29b-p53 pathway in cancer cells

21 enhanced efficacy of doxorubicin by microrna-499-mediated improvement of tumor blood flow

22 systemic therapy of cancer: facts and expectations

23 targeted and effective photodynamic therapy for cancer using functionalized nanomaterials

24 the novel small molecule stk899704 promotes senescence of the human a549 nsclc cells by inducing dna damage responses and cell cycle arrest

25 the role of heparanase and sulfatases in the modification of heparan sulfate proteoglycans within the tumour microenvironment and opportunities for novel cancer therapeutics

26 nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry–based imaging

27 an abraded surface of doxorubicin-loaded surfactant-containing drug delivery systems effectively reduces the survival of carcinoma cells

28 Local microwave hyperthermia (43� C) and stimulation of the macrophage and T-lymphocyte systems in treatment of Guerin epithelioma in rats

29 Interrogating open issues in cancer precision medicine with patient-derived xenografts - Nature Reviews Cancer

30 Recovery and self-management support following primary cancer treatment - British Journal of Cancer

31 The health and well-being of cancer survivors in the UK: findings from a population-based survey - British Journal of Cancer

32 Enhancing melanoma therapy with hydrogel microneedles.

33 Mechanistic Insights and Therapeutic Potentials of Ubiquitin-Proteasome System in Non-Small Cell Lung Cancer.

34 Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy.

35 Targeting mitochondria with Au-Ag@Polydopamine nanoparticles for papillary thyroid cancer therapy.

36 Synthetic lethal interaction between oxidative stress response and DNA damage repair in the budding yeast and its application to targeted anticancer therapy.

37 PEG-derivatized birinapant as a nanomicellar carrier of paclitaxel delivery for cancer therapy.

38 Challenges and Contradictions of Metal Nano-Particle Applications for Radio-Sensitivity Enhancement in Cancer Therapy.

39 Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy

40 Colloidal plasmonic gold nanoparticles and gold nanorings: shape-dependent generation of singlet oxygen and their performance in enhanced photodynamic cancer therapy

41 Molecular Docking based analysis to elucidate the DNA Topoisomerase IIβ as the potential target for the Ganoderic acid, A natural therapeutic agent in cancer therapy.

42 Cell intrinsic hallmarks (Frequency and Bioelectrical potential) sensitive nano-carriers for cancer therapy: A lost option in research

43 Nuclear-targeted p53 and DOX co-delivery of chitosan derivatives for cancer therapy in vitro and in vivo.

44 Gastric environment-stable oral nanocarriers for in situ colorectal cancer therapy.

45 Glucose Oxidase-Instructed Multimodal Synergistic Cancer Therapy.

46 pH-Responsive Polymer-Stabilized ZIF-8 Nanocomposite for Fluorescence and Magnetic Resonance Dual-Modal Imaging-Guided Chemo/Photodynamic Combinational Cancer Therapy.

47 A promising cancer diagnosis and treatment strategy: targeted cancer therapy and imaging based on antibody fragment.

48 ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology

49 Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy.

50 Effects of doctor networking on diffusion of new cancer therapy

51 Poly(Cyclohexene Phthalate) Nanoparticles for Controlled Dasatinib Delivery in Breast Cancer Therapy.

52 Sequentially Site-Specific Delivery of Apoptotic Protein and Tumor-Suppressor Gene for Combination Cancer Therapy.

53 Dual drug loaded PLGA nanospheres for synergistic efficacy in breast cancer therapy.

54 Drug Carrier for Photodynamic Cancer Therapy

55 Systematic Review on Cytotoxic and Anticancer Potential of N-Substituted Isatins as Novel Class of Compounds Useful in Multidrug-Resistant Cancer Therapy: In Silico and In Vitro Analysis.

56 Emerging Glycolysis Targeting and Drug Discovery from Chinese Medicine in Cancer Therapy

57 Renal-clearable ultrasmall covalent organic framework nanodots as photodynamic agents for effective cancer therapy.

58 Iron Release Profile of Silica-Modified Zero-Valent Iron NPs and Their Implication in Cancer Therapy.

59 A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance

60 HIF-1 dependent reversal of cisplatin resistance via anti-oxidative nano selenium for effective cancer therapy

61 Efficiency of the Green Synthesized Nanoparticles as New Tools in Cancer Therapy: Insights on Plant-Based Bioengineered Nanoparticles, Biophysical Properties, and Anticancer Roles.

62 Tumor Microenvironment Targeted Nanotherapeutics for Cancer Therapy and Diagnosis: A review.

63 Gold nanoparticle mediated combined cancer therapy

64 Ag@FeO@C nanoparticles for multi-modal imaging-guided chemo-photothermal synergistic targeting for cancer therapy.

65 Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo

66 Activatable Phototheranostic Materials for Imaging-Guided Cancer Therapy.

67 Corrigendum to “Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapy” (Materials Science & Engineering C (2019) 102 (113–123), (S0928493118320290), (10.1016/j.msec.2019.03.009))

68 Photothermal cancer therapy using graphitic carbon–coated magnetic particles prepared by one-pot synthesis

69 Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review.

70 A case report of monitoring PSA level changes in two prostate cancer patients treated with Mountain Ginseng Pharmacopuncture and Sweet Bee Venom along with western anticancer therapy

71 Polymeric Core-Shell Combinatorial Nanomedicine for Synergistic Anticancer Therapy.

72 Theranostic nanobubble encapsulating a plasmon-enhanced upconversion hybrid nanosystem for cancer therapy.

73 Thiazole-containing compounds as therapeutic targets for cancer therapy.

74 Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy.

75 Magnetic Driven Nanocarriers for pH-Responsive Doxorubicin Release in Cancer Therapy.

76 Entropically driven controlled release of paclitaxel from poly(2-ethyl-2-oxazoline) coated maghemite nanostructures for magnetically guided cancer therapy.

77 Magnetically guided delivery of DHA and Fe ions for enhanced cancer therapy based on pH-responsive degradation of DHA-loaded Fe<inf>3</inf>O<inf>4</inf>@C@MIL-100(Fe) nanoparticles

78 Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.

79 Facile Strategy by Hyaluronic Acid Functional Carbon Dot-Doxorubicin Nanoparticles for CD44 Targeted Drug Delivery and Enhanced Breast Cancer Therapy.

80 Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.

81 Fertility considerations, counseling, and semen cryopreservation for males prior to the initiation of cancer therapy.

82 State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.

83 NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy

84 Surface-Initiated Atom Transfer Polymerized Anionic Corona on Gold Nanoparticles for Anti-Cancer Therapy.

85 Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19.

86 Challenges in lung cancer therapy during the COVID-19 pandemic.

87 Targeting cancer stem cell pathways for cancer therapy

88 Tyrosine kinases as targets in cancer therapy – successes and failures

89 protein nanoparticles as drug delivery carriers for cancer therapy

90 adverse events of monoclonal antibodies used for cancer therapy

91 cell death signaling and anticancer therapy

92 radiolabeled antibody fragment for preparation of (<sub>177</sub>lu-dota)<sub>m</sub>-pamam g3.0-f(ab’)<sub>2</sub> trastuzumab as a radiopharmaceutical for cancer therapy

93 neuropilins: a new target for cancer therapy

94 gene expression analysis identifies novel targets for cervical cancer therapy

95 oxidants and redox signaling: perspectives in cancer therapy, inflammation, and plasma medicine

96 monoclonal antibodies as immune modulators for cancer therapy

97 antibody–drug conjugates for cancer therapy

98 autophagy therapeutic potential of garlic in human cancer therapy

99 medicinal plants from near east for cancer therapy

100 toll-like receptor 9 agonists for cancer therapy

101 design and synthesis of isosteviol triazole conjugates for cancer therapy